Back
ARS Pharmaceuticals Vs. Axon Enterprise Industry Stock Comparison
Buy
68
SPRY
ARS Pharmaceuticals
Last Price:
16.58
Seasonality Move:
12.23%
Buy
99
AXON
Axon Enterprise
Last Price:
595.25
Seasonality Move:
18.01%
Buy
68
ARS Pharmaceuticals (SPRY)
is a Buy
Is ARS Pharmaceuticals a Buy, Sell or Hold?
- The current ARS Pharmaceuticals [SPRY] share price is $17.49. The Score for SPRY is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- SPRY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
99
Axon Enterprise (AXON)
is a Buy
Is Axon Enterprise a Buy, Sell or Hold?
- The current Axon Enterprise [AXON] share price is $616.14. The Score for AXON is 99, which is 98% above its historic median score of 50, and infers lower risk than normal.
- AXON is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
SPRY Stock Price Chart
What is ARS Pharmaceuticals's stock price today?
-
The ARS Pharmaceuticals share price today is $17.49
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPRY is experiencing slight selling pressure.
AXON Stock Price Chart
What is Axon Enterprise's stock price today?
-
The Axon Enterprise share price today is $616.14
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AXON is experiencing buying pressure, which is a positive indicator for future bullish movement.
SPRY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.55 | Buy |
| Relative Strength Index (14 RSI): | 68.58 | Buy |
| Chaikin Money Flow: | -882302 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.45 - 16.43) | Buy |
| Bollinger Bands (100): | (10.26 - 15.08) | Buy |
AXON Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 33.5 | Buy |
| Relative Strength Index (14 RSI): | 91.12 | Buy |
| Chaikin Money Flow: | 943961 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (404.66 - 500.1) | Buy |
| Bollinger Bands (100): | (307.31 - 434.07) | Buy |
SPRY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.87 | Buy |
| 20-day SMA: | 15.75 | Buy |
| 50-day SMA: | 14.39 | Buy |
| 200-day SMA: | 10.62 | Buy |
| 8-day EMA: | 16.2 | Buy |
| 20-day EMA: | 15.6 | Buy |
| 50-day EMA: | 14.55 | Buy |
| 200-day EMA: | 11.2 | Buy |
AXON Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 483.83 | Buy |
| 20-day SMA: | 458.3 | Buy |
| 50-day SMA: | 417.81 | Buy |
| 200-day SMA: | 332.5 | Buy |
| 8-day EMA: | 511.84 | Buy |
| 20-day EMA: | 468.72 | Buy |
| 50-day EMA: | 426.74 | Buy |
| 200-day EMA: | 342.79 | Buy |
ARS Pharmaceuticals Earnings Growth & SPRY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and a decrease next year of $0.13 per share.
Axon Enterprise Earnings Growth & AXON Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.32 per share, and an increase next year of $1.00 per share.
ARS Pharmaceuticals Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Axon Enterprise Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||